Anisakis pegreffii Extract Induces Airway Inflammation with Airway Remodeling in a Murine Model System.

Abstract

Exposure of the respiratory system to the Anisakis pegreffii L3 crude extract (AE) induces airway inflammation; however, the mechanism underlying this inflammatory response remains unknown. AE contains allergens that promote allergic inflammation; exposure to AE may potentially lead to asthma. In this study, we aimed to establish a murine model to assess the effects of AE on characteristic features of chronic asthma, including airway hypersensitivity (AHR), airway inflammation, and airway remodeling. Mice were sensitized for five consecutive days each week for 4 weeks. AHR, lung inflammation, and airway remodeling were evaluated 24 h after the last exposure. Lung inflammation and airway remodeling were assessed from the bronchoalveolar lavage fluid (BALF). To confirm the immune response in the lungs, changes in gene expression in the lung tissue were assessed with reverse transcription-quantitative PCR. The levels of IgE, IgG1, and IgG2a in blood and cytokine levels in the BALF, splenocyte, and lung lymph node (LLN) culture supernatant were measured with ELISA. An increase in AHR was prominently observed in AE-exposed mice. Epithelial proliferation and infiltration of inflammatory cells were observed in the BALF and lung tissue sections. Collagen deposition was detected in lung tissues. AE exposure increased IL-4, IL-5, and IL-13 expression in the lung, as well as the levels of antibodies specific to AE. IL-4, IL-5, and IL-13 were upregulated only in LLN. These findings indicate that an increase in IL-4+ CD4+ T cells in the LLN and splenocyte resulted in increased Th2 response to AE exposure. Exposure of the respiratory system to AE resulted in an increased allergen-induced Th2 inflammatory response and AHR through accumulation of inflammatory and IL-4+ CD4+ T cells and collagen deposition. It was confirmed that A. pegreffii plays an essential role in causing asthma in mouse models and has the potential to cause similar effects in humans.

• Authors: Jun Ho Choi, Ju Yeong Kim, Myung-Hee Yi, Myungjun Kim, Tai-Soon Yong
• Journal: BioMed research international (Biomed Res Int) Vol. 2021 Pg. 2522305 ( 2021) ISSN: 2314-6141 [Electronic] United States
• PMID: 34580637 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Jun Ho Choi et al.

Chemical References

• Biomarkers
• Cytokines
• Inflammation Mediators
• Methacholine Chloride

Topics

• Airway Remodeling (drug effects)
• Animals
• Anisakis (physiology)
• Antibody Specificity (immunology)
• Biomarkers (metabolism)
• Bronchial Hyperreactivity (blood, complications, physiopathology)
• Cytokines (metabolism)
• Disease Models, Animal
• Inflammation Mediators (metabolism)
• Lung (drug effects, physiopathology)
• Methacholine Chloride (pharmacology)
• Mice, Inbred BALB C
• Pneumonia (blood, complications, parasitology, physiopathology)
• Th2 Cells (metabolism)